A Vancouver-led research initiative to prevent deaths of moms and babies got a boost recently with a new $1.5-million grant from the Bill & Melinda Gates Foundation. The grant will expand efforts to improve diagnosis and care for pregnant women with pre-eclampsia.

 

New research shows sugary drinks are the worst offenders in the fight against youth obesity and recommends that B.C. schools fully implement healthy eating guidelines to reduce their consumption.

A team of researchers at CFRI, CMMT, BC Children’s, and UBC have uncovered a genetic cause of excess ammonia in the blood of newborns, increasing the chances that children can be treated before suffering permanent brain damage.

A team of researchers at Centre for Molecular Medicine and Therapeutics (CMMT) and CFRI, led by Dr. Blair Leavitt, recently described a promising approach that alleviates the symptoms of ALS in mice, according to new data published in the scientific journal Nature Communications.

A clinical tool to aid in diagnosing 81 rare inborn errors of metabolism that are potentially treatable is now being by used by an average of 1200 clinicians and scientists every month. 

Dr. Ran Goldman reviews current research to provide evidence-based responses to physician questions in his column in Canadian Family Physician, the official journal of The College of Family Physicians of Canada. This month, Dr. Goldman and pediatric resident Dr. Adela Matejcek address a question about a routine delivery room procedure.

New research published yesterday in the medical journal Pediatrics shows the standard treatment of intravenous (IV) magnesium does not reduce hospital length of stay or lower pain scores for children with acute episodes of sickle cell disease.

Dr. Wyeth Wasserman has been appointed the Executive Director of the Child & Family Research Institute (CFRI) and The University of British Columbia (UBC) Faculty of Medicine Associate Dean, Research, CFRI.

CFRI research has narrowed the hunt for molecules that regulate survival of the body’s insulin-producing cells.

A CFRI-led team has reported the first clinical trial of an automated anesthesia drug delivery system for children, a major step towards more personalized anesthesia.

As students are heading into mid-terms, doctors and parents alike are concerned about children’s and adolescents’ consumption of caffeinated energy drinks. Dr. Ran Goldman, emergency room physician, paediatrician, and researcher with CFRI’s Innovations in Acute Care & Technology group, addresses these concerns in his most recent column in Canadian Family Physician, the peer-reviewed publication of the College of Family Physicians in Canada.

Development of a vaccine against Epstein-Barr virus (EBV) has taken a step forward with the Canadian discovery of how EBV infection evades detection by the immune system. 

A new study has shone a spotlight on the peacekeeping mechanisms in our intestines.

One size chart doesn’t fit all when it comes to evaluating birth weight and health outcomes of newborns.

Immigrant and refugee kids face many of challenges when they arrive in Canada. As a health professional, you're there to help them. To help you, our partners at the Canadian Paediatric Society have launched a www.kidsnewtocanada.ca, an online guide for health professionals working with immigrant and refugee children, youth and families.

Since the Vaccine Evaluation Centre (VEC) was founded as the first of its kind in Canada in 1988, the centre’s investigators have completed over 225 research studies with findings that have contributed towards developing new vaccines, improving vaccine safety, and refining public immunization programs.

The calls are coming with greater frequency, and greater urgency, from parents of children who have suffered a concussion, or might have suffered a concussion. They want clear, authoritative guidance, or a second opinion.

Two doses of Merck & Co.'s human papillomavirus vaccine may be just as effective in younger girls as the recommended three doses given to older teens and women to help protect them against the virus that causes cervical cancer, a Canadian study found.

Three doses of the human papillomavirus (HPV) vaccine are needed in order for the vaccine to be effective, health officials say, but many people who start the vaccination series don't finish it.